Progyny (NASDAQ:PGNY – Get Rating) issued an update on its FY 2022 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of $0.14-$0.19 for the period, compared to the consensus estimate of $0.09. The company issued revenue guidance of $750.00 million-$775.00 million, compared to the consensus revenue estimate of $756.81 million. Progyny also updated its FY22 guidance to $0.14-$0.19 EPS.
Progyny Stock Performance
PGNY traded up $11.38 on Friday, hitting $41.15. 3,469,925 shares of the company were exchanged, compared to its average volume of 684,594. The stock has a market capitalization of $3.78 billion, a PE ratio of 89.46, a price-to-earnings-growth ratio of 21.71 and a beta of 1.85. Progyny has a 12 month low of $25.67 and a 12 month high of $68.32. The firm has a fifty day simple moving average of $30.23 and a two-hundred day simple moving average of $37.32.
Progyny (NASDAQ:PGNY – Get Rating) last issued its quarterly earnings data on Thursday, August 4th. The company reported $0.09 earnings per share for the quarter, topping analysts' consensus estimates of $0.05 by $0.04. The firm had revenue of $195.00 million for the quarter, compared to analyst estimates of $190.51 million. Progyny had a return on equity of 18.11% and a net margin of 7.39%. The business's quarterly revenue was up 51.5% compared to the same quarter last year. During the same period last year, the company earned $0.19 EPS. On average, equities analysts expect that Progyny will post 0.17 earnings per share for the current year.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently bought and sold shares of PGNY. Clearbridge Investments LLC boosted its position in Progyny by 2.7% during the 1st quarter. Clearbridge Investments LLC now owns 3,223,502 shares of the company's stock valued at $165,688,000 after acquiring an additional 86,249 shares in the last quarter. State Street Corp raised its stake in shares of Progyny by 4.0% during the 1st quarter. State Street Corp now owns 2,075,678 shares of the company's stock valued at $106,690,000 after buying an additional 80,100 shares during the last quarter. Dai Ichi Life Insurance Company Ltd purchased a new position in shares of Progyny during the 1st quarter valued at about $3,069,000. Owls Nest Partners IA LLC grew its position in shares of Progyny by 9.8% during the 1st quarter. Owls Nest Partners IA LLC now owns 601,387 shares of the company's stock valued at $30,911,000 after acquiring an additional 53,836 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Progyny by 0.8% during the 1st quarter. Vanguard Group Inc. now owns 6,525,283 shares of the company's stock valued at $335,399,000 after acquiring an additional 49,779 shares during the period. Institutional investors own 82.51% of the company's stock.
几家对冲基金和其他机构投资者最近买卖了PGNY的股票。ClearBridge Investments LLC在第一季度将其在Progyny的头寸增加了2.7%。ClearBridge Investments LLC在上个季度增持了86,249股后，现在拥有3,223,502股该公司股票，价值165,688,000美元。道富银行在第一季度增持了4.0%的Progyny股票。道富银行目前持有该公司2,075,678股股票，价值106,690,000美元，此前该公司在上个季度又购买了80,100股票。第一季度，Dai Ichi Life Insurance Company Ltd购买了Progyny的新股票头寸，价值约3,069,000美元。Ols Nest Partners IA LLC在第一季度将其在Progyny的股票头寸增加了9.8%。Ols Nest Partners IA LLC在此期间增持了53,836股，目前拥有601,387股该公司股票，价值30,911,000美元。最后，先锋集团(Vanguard Group Inc.)在第一季度将其在Progyny的股票头寸增加了0.8%。先锋集团在此期间增持了49,779股，目前持有该公司6,525,283股股票，价值335,399,000美元。机构投资者持有该公司82.51%的股份。
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/1 – 8/5
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Cronos Group Inc's Revenues Are Up, Is It Time to Buy?
- Why Apple Could Be At All-Time Highs By Year End
- Beyond Meat Is Not Beyond Hope, And It's Cheap
- 克罗诺斯集团(Cronos Group Inc.)营收上升，是时候收购了吗？
- Beyond Meat不是没有希望，而且它很便宜
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.